Cargando…

Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective

SARS-CoV-2 represents the causative agent of the current pandemic (COVID-19). The drug repurposing technique is used to search for possible drugs that can bind to SARS-CoV-2 proteins and inhibit viral replication. In this study, the FDA-approved antiplatelets are tested against the main protease and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abosheasha, Mohammed A., El-Gowily, Afnan H., Elfiky, Abdo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435103/ https://www.ncbi.nlm.nih.gov/pubmed/34510337 http://dx.doi.org/10.1007/s11239-021-02558-5

Ejemplares similares

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022)

Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective
por: Elshemey, Wael M., et al.
Publicado: (2022)

Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
por: Sonousi, Amr, et al.
Publicado: (2021)

Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective
por: Ibrahim, Ibrahim M., et al.
Publicado: (2021)

SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective
por: Elfiky, Abdo A., et al.
Publicado: (2022)

Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
por: Mahmud, Shafi, et al.
Publicado: (2021)

Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico
por: Elfiky, Abdo A, et al.
Publicado: (2021)

The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico
por: Elfiky, Abdo A., et al.
Publicado: (2021)

Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view
por: Elfiky, Abdo A, et al.
Publicado: (2022)

Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (M(pro))
por: Abu-Melha, Sraa, et al.
Publicado: (2020)

GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective
por: Elgohary, Alaa M., et al.
Publicado: (2021)

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective
por: Ogunyemi, Oludare M, et al.
Publicado: (2020)

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
por: Elfiky, Abdo A.
Publicado: (2020)

Regulation of Protein-Induced Apoptosis and Autophagy in Human Hepatocytes Treated with Metformin and Paclitaxel In Silico and In Vitro
por: Al-Zahrani, Norah Saeed, et al.
Publicado: (2023)

Chemical constituents from Limonium tubiflorum and their in silico evaluation as potential antiviral agents against SARS-CoV-2
por: Hassan, Ahmed R., et al.
Publicado: (2021)

Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2
por: Elsbaey, Marwa, et al.
Publicado: (2021)

SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses
por: Elfiky, Abdo A.
Publicado: (2020)

Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M(pro)) inhibitors to unveil a hope against COVID-19
por: Adem, Şevki, et al.
Publicado: (2022)

Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico
por: Abduljalil, Jameel M., et al.
Publicado: (2023)

Correction to: Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study
por: Elfiky, Abdo A., et al.
Publicado: (2016)

In silico evidence of beauvericin antiviral activity against SARS-CoV-2
por: Al Khoury, Charbel, et al.
Publicado: (2022)

SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic
por: Ismail, Alaa M., et al.
Publicado: (2020)

An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever
por: Powers, Chelsea N., et al.
Publicado: (2016)

Synthesis and In Silico Study of Some New bis-[1,3,4]thiadiazolimines and bis-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main Protease
por: Gomha, Sobhi M., et al.
Publicado: (2022)

Essential Oils as Antiviral Agents, Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation
por: da Silva, Joyce Kelly R., et al.
Publicado: (2020)

Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2
por: Attia, Gouda H., et al.
Publicado: (2021)

Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis
por: Ibrahim, Ibrahim M., et al.
Publicado: (2022)

Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil–CNPs) against SARS-CoV-2 (in silico and in vitro study)
por: Loutfy, Samah A., et al.
Publicado: (2022)

Exploration of In-silico screening of therapeutic agents against SARS-CoV-2
por: Thakur, Yamini, et al.
Publicado: (2021)

New emerging SARS-CoV-2 variants and antiviral agents
por: Vitiello, A., et al.
Publicado: (2023)

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
por: Elfiky, Abdo A.
Publicado: (2020)

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents
por: Ahmed, Mohammad Z., et al.
Publicado: (2021)

Host-cell recognition of SARS-CoV-2 spike receptor binding domain from different variants
por: Elfiky, Abdo A, et al.
Publicado: (2022)

Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase
por: Elfiky, Abdo A., et al.
Publicado: (2022)

Inhibition of SARS-CoV2 viral infection with natural antiviral plants constituents: An in-silico approach
por: Das, Kuntal, et al.
Publicado: (2023)

Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach
por: Goyzueta-Mamani, Luis Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqq9f80nijqp1rkqkhejb3knms